Laura Sepp-Lorenzino

358 posts

Laura Sepp-Lorenzino

Laura Sepp-Lorenzino

@LauraSepplore

CSO @Intelliatx 🇺🇸🇦🇷 #GeneEditing #CRISPR #WomenInSTEM Opinions/likes/RT mine & not endorsements.

Boston, MA Katılım Nisan 2014
349 Takip Edilen973 Takipçiler
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino@LauraSepplore·
I am honored to join the Board of @ask_bio Inc. during such a pivotal moment as it advances its clinical and pre-clinical programs toward major milestones. Eager to help realize the full potential of these groundbreaking medicines! #CGT #genetherapy #AAV #BOD
AskBio Inc. (AskBio)@ask_bio

We’re proud to welcome Dr. Laura Sepp-Lorenzino to AskBio’s Board of Directors! With 30+ years of leadership in biotech, her insights will be key as we advance our clinical and pre-clinical #GeneTherapy candidates. Learn more: bit.ly/4crLjQj #AskBio #Leadership

English
2
1
10
565
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino@LauraSepplore·
We made the tough call to restructure our business operations, affecting many of our skilled colleagues. I am committed to supporting them through this transition and serving as a personal reference where I can. Your consideration is greatly appreciated. #ONEintellia #talent
Intellia Therapeutics@intelliatx

$NTLA announces its 2025 goals to support the company’s mission to transform the lives of patients and bring forth a new era in medicine: tinyurl.com/3yepvz89 #CRISPR #GeneEditing

English
0
1
18
1.1K
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino@LauraSepplore·
Wishing you a year filled with positivity, creativity, and a commitment to making the world a better place. Let's embrace each day with a spirit of discovery and a drive to create beauty around us. Here's to a year of growth, kindness, and meaningful contributions. #NewYear2025
English
0
0
15
388
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino@LauraSepplore·
Impressive data update from our nex-z program (aka NTLA-2001 for #ATTR)! Congrats to all! Teamwork makes the dream work. #OneIntellia
Intellia Therapeutics@intelliatx

#ATTR News: $NTLA announces positive new clinical data from the ongoing Phase 1 trial of nexiguran ziclumeran (nex-z) in patients with #ATTR amyloidosis with cardiomyopathy. Full details here: tinyurl.com/33buvne7. Join us at 12 p.m. ET for a webcast discussing the data, as well as an update from the ongoing Phase 1 polyneuropathy cohort. event.choruscall.com/mediaframe/web… #CRISPR #GeneEditing

English
2
5
44
4.2K
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino@LauraSepplore·
This encouraging data update brings us one step closer to making CRISPR-based medicines a reality through innovative science. Excited for the future as we continue to move forward! #HAE #CRISPR #OneIntellia
Intellia Therapeutics@intelliatx

#HAE $NTLA News: Intellia presents positive results from the Phase 2 study of NTLA-2002 for #hereditaryangioedema at the @ACAAI Scientific Meeting in Boston. Details here: ir.intelliatx.com/news-releases/…

English
1
2
23
1.5K
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino@LauraSepplore·
Delivery, delivery, delivery! Join us in Siracusa, Italy from April 4-7 to discuss new advances in nucleic acid delivery and how to solve the remaining challenges! Don't miss this opportunity. Abstract deadline is March 15, 2024. Register here: #header4" target="_blank" rel="nofollow noopener">engconf.us/conferences/bi…
Laura Sepp-Lorenzino tweet media
English
1
5
25
1.7K
Laura Sepp-Lorenzino
Laura Sepp-Lorenzino@LauraSepplore·
Two for two! Congrats to the team on our second @NEJM publication demonstrating the promise of #CRISPR!
English
2
7
48
3.1K